Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Screening the Pathogen Box for Molecules Active against Plasmodium Sexual Stages Using a New Nanoluciferase-Based Transgenic Line of P-berghei Identifies Transmission-Blocking Compounds

Full text
Author(s):
Calit, Juliana [1] ; Dobrescu, Irina [1] ; Gaitan, Xiomara A. [1] ; Borges, Miriam H. [1] ; Ramos, Marise S. [1] ; Eastman, Richard T. [2] ; Bargieri, Daniel Y. [1]
Total Authors: 7
Affiliation:
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo - Brazil
[2] NIH, Div Preclin Innovat, Natl Ctr Advancing Translat Sci, Rockville, MD - USA
Total Affiliations: 2
Document type: Journal article
Source: Antimicrobial Agents and Chemotherapy; v. 62, n. 11 NOV 2018.
Web of Science Citations: 4
Abstract

Malaria remains an important parasitic disease with a large morbidity and mortality burden. Plasmodium transmission-blocking (TB) compounds are essential for achieving malaria elimination efforts. Recent efforts to develop high-throughput screening (HTS) methods to identify compounds that inhibit or kill gametocytes, the Plasmodium sexual stage infectious to mosquitoes, have yielded insight into new TB compounds. However, the activities of these compounds against gametes, formed in the first minutes of mosquito infection, are typically not assessed, unless screened in a standard membrane feeding assay, a labor-intensive assay. We demonstrate here the generation of a Plasmodium model for drug screens against gametes and fertilization. The new P. berghei line, named Ookluc, was genetically and pharmacologically validated and scalable for HTS. Screening the Pathogen Box from the Medicines for Malaria Venture using the new model identified promising TB compounds. The use of Ookluc in different libraries of compounds may aid in the identification of transmission-blocking drugs not assessed in screens against asexual stages or gametocytes. (AU)

FAPESP's process: 14/23083-1 - Plasmodium vivax vaccine development and antigen discovery using P. berghei malaria models.
Grantee:Irina Dobrescu
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 13/13119-6 - Cell biology and molecular genetics of hemoparasites
Grantee:Daniel Youssef Bargieri
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 16/16649-4 - Expression, purification and immunological analysis of p. berghei MTRAP
Grantee:Xiomara Alexandra Gaitán
Support Opportunities: Scholarships in Brazil - Master